APA (7th ed.) Citation

Lanz, T., Williams-Fairless, S. K., Stojic, A., Sonner, J. K., Becker, S., Böhler, L., . . . Platten, M. (2017). Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis. Scientific reports, 7, . https://doi.org/10.1038/srep41271

Chicago Style (17th ed.) Citation

Lanz, Tobias, et al. "Tryptophan-2,3-Dioxygenase (TDO) Deficiency Is Associated with Subclinical Neuroprotection in a Mouse Model of Multiple Sclerosis." Scientific Reports 7 (2017). https://doi.org/10.1038/srep41271.

MLA (9th ed.) Citation

Lanz, Tobias, et al. "Tryptophan-2,3-Dioxygenase (TDO) Deficiency Is Associated with Subclinical Neuroprotection in a Mouse Model of Multiple Sclerosis." Scientific Reports, vol. 7, 2017, https://doi.org/10.1038/srep41271.